UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Virtual Twins: Understanding the Data Required for Model‐Informed Precision Dosing

Clinical pharmacology and therapeutics, 2020-04, Vol.107 (4), p.742-745

2020

Volltextzugriff (PDF)

Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment

Alimentary pharmacology & therapeutics, 2021-08, Vol.54 (4), p.388-401

2021

Volltextzugriff (PDF)

Physiological‐based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20‐years; in‐depth analysis of applications, organizations, and platforms

Biopharmaceutics & drug disposition, 2021-04, Vol.42 (4), p.107-117

2021

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetics as a Component of Model‐Informed Drug Development: Where We Were, Where We Are, and Where We Are Heading

Journal of clinical pharmacology, 2020-10, Vol.60 (S1 Suppl 1), p.S12-S16

2020

Volltextzugriff (PDF)

Linking in vitro–in vivo extrapolations with physiologically based modeling to inform drug and formulation development

Biopharmaceutics & drug disposition, 2023-08, Vol.44 (4), p.289-291

2023

Volltextzugriff (PDF)

Scientific considerations to move towards biowaiver for biopharmaceutical classification system class III drugs: How modeling and simulation can help

Biopharmaceutics & drug disposition, 2021-04, Vol.42 (4), p.118-127

2021

Volltextzugriff (PDF)

In-depth analysis of patterns in selection of different physiologically-based pharmacokinetic modeling tools: Part II - Assessment of model reusability and comparison between open and non-open source-code software

Biopharmaceutics & drug disposition, 2023-08, Vol.44 (4), p.292-300

2023

Volltextzugriff (PDF)

Toward a Consensus on Applying Quantitative Liquid Chromatography‐Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper

Clinical pharmacology and therapeutics, 2019-09, Vol.106 (3), p.525-543

2019

Volltextzugriff (PDF)

Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice

Pediatric anesthesia, 2011-03, Vol.21 (3), p.291-301

2011

Volltextzugriff (PDF)

Identification and quantification of blood–brain barrier transporters in isolated rat brain microvessels

Journal of neurochemistry, 2018-09, Vol.146 (6), p.670-685

2018

Volltextzugriff (PDF)

In‐depth analysis of patterns in selection of different physiologically based pharmacokinetic modeling tools: Part I – Applications and rationale behind the use of open source‐code software

Biopharmaceutics & drug disposition, 2023-06, Vol.44 (3), p.274-285

2023

Volltextzugriff (PDF)

Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19

British journal of clinical pharmacology, 2014-03, Vol.77 (3), p.554-570

2014

Volltextzugriff (PDF)

Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence

Clinical pharmacology and therapeutics, 2018-02, Vol.103 (2), p.224-232

Rostami‐Hodjegan, Amin

2018

Volltextzugriff (PDF)

Does “Birth” as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full‐Term Neonates by Avoiding the Creatinine Bias

Journal of clinical pharmacology, 2021-02, Vol.61 (2), p.159-171

2021

Volltextzugriff (PDF)

A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates

Drug metabolism and pharmacokinetics, 2009-01, Vol.24 (1), p.53-75

2009

Volltextzugriff (PDF)

Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults

Biopharmaceutics & drug disposition, 2015-05, Vol.36 (4), p.245-257

2015

Volltextzugriff (PDF)

Opening a debate on open‐source modeling tools: Pouring fuel on fire versus extinguishing the flare of a healthy debate

CPT: pharmacometrics and systems pharmacology, 2021-05, Vol.10 (5), p.420-427

2021

Volltextzugriff (PDF)

Combining the ‘bottom up’ and ‘top down’ approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data

British journal of clinical pharmacology, 2015-01, Vol.79 (1), p.48-55

2015

Volltextzugriff (PDF)

Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future clinical trials

Clinical and translational science, 2023-05, Vol.16 (5), p.742-758

2023

Volltextzugriff (PDF)

GASP and FASP are Complementary for LC–MS/MS Proteomic Analysis of Drug‐Metabolizing Enzymes and Transporters in Pig Liver

Proteomics (Weinheim), 2018-12, Vol.18 (24), p.e1800200-n/a

2018

Volltextzugriff (PDF)

A proposal for scientific framework enabling specific population drug dosing recommendations

Journal of clinical pharmacology, 2015-10, Vol.55 (10), p.1073-1078

2015

Volltextzugriff (PDF)

Do Children Have the Same Vulnerability to Metabolic Drug-Drug Interactions as Adults? A Critical Analysis of the Literature

Journal of clinical pharmacology, 2013-05, Vol.53 (5), p.559-566

2013

Volltextzugriff (PDF)

Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters

CPT: pharmacometrics and systems pharmacology, 2021-05, Vol.10 (5), p.467-477

2021

Volltextzugriff (PDF)

Assessing Potential Drug–Drug Interactions Between Dabigatran Etexilate and a P‐Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling

CPT: pharmacometrics and systems pharmacology, 2019-02, Vol.8 (2), p.118-126

2019

Volltextzugriff (PDF)

Is Liquid Biopsy Only Restricted to Diagnostics or Can it Go Beyond the Confines of Genotyping and Phenotyping for Quantitative Pharmacology?

Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1152-1153

2022

Volltextzugriff (PDF)

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(275)

Publikationsform

Sprache

Englisch
(333)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(242)
Life Sciences & Biomedicine
(240)
Pharmacology & Pharmacy
(217)
Humans
(169)
Models, Biological
(99)
Pharmacokinetics
(74)
Female
(58)
Male
(51)
Pharmaceutical Preparations - Metabolism
(50)
Adult
(46)
Biological And Medical Sciences
(45)
Pharmacology/toxicology
(44)
Medical Sciences
(43)
Computer Simulation
(38)
Pharmacology. Drug Treatments
(38)
Animals
(34)
Liver - Metabolism
(33)
Biomedical And Life Sciences
(32)
Biomedicine
(32)
Biochemistry
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Virtual Twins: Understanding the Data Required for Model‐Informed Precision Dosing

Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment

Physiological‐based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20‐years; in‐depth analysis of applications, organizations, and platforms

Physiologically Based Pharmacokinetics as a Component of Model‐Informed Drug Development: Where We Were, Where We Are, and Where We Are Heading

Linking in vitro–in vivo extrapolations with physiologically based modeling to inform drug and formulation development

Scientific considerations to move towards biowaiver for biopharmaceutical classification system class III drugs: How modeling and simulation can help

In-depth analysis of patterns in selection of different physiologically-based pharmacokinetic modeling tools: Part II - Assessment of model reusability and comparison between open and non-open source-code software

Toward a Consensus on Applying Quantitative Liquid Chromatography‐Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper

Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice

Identification and quantification of blood–brain barrier transporters in isolated rat brain microvessels

In‐depth analysis of patterns in selection of different physiologically based pharmacokinetic modeling tools: Part I – Applications and rationale behind the use of open source‐code software

Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19

Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence

Does “Birth” as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full‐Term Neonates by Avoiding the Creatinine Bias

A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates

Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults

Opening a debate on open‐source modeling tools: Pouring fuel on fire versus extinguishing the flare of a healthy debate

Combining the ‘bottom up’ and ‘top down’ approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data

Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future clinical trials

GASP and FASP are Complementary for LC–MS/MS Proteomic Analysis of Drug‐Metabolizing Enzymes and Transporters in Pig Liver

A proposal for scientific framework enabling specific population drug dosing recommendations

Do Children Have the Same Vulnerability to Metabolic Drug-Drug Interactions as Adults? A Critical Analysis of the Literature

Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters

Assessing Potential Drug–Drug Interactions Between Dabigatran Etexilate and a P‐Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling

Is Liquid Biopsy Only Restricted to Diagnostics or Can it Go Beyond the Confines of Genotyping and Phenotyping for Quantitative Pharmacology?

Suchergebnisse filtern